Lack of specific: Target. Your question implies that cancer cells have unique cell surface markers to which monoclonal antibodies could be directed and that is not valid. Tumor cells usually do not have markers not present on normal cells and there is marked variation among tumor cells within a given tumor.
Answered 6/27/2012
5.8k views
A doctor has provided 1 answer
A doctor has provided 1 answer
7 doctors weighed in across 2 answers
A doctor has provided 1 answer
4 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question